MedPath

AMITIZA

AMITIZA

Discontinued
DIN Number

02447363

Drug Class

Human

Market Date

N/A

Company
HC

Sucampo Pharma Americas LLC

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02447363
AIG Number0157490001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
A06AX03 LUBIPROSTONE
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification56:92.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

LUBIPROSTONEActive
Strength: 24 MCG
Monograph: LUBIPROSTONE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.